外商直接投资对中国医药制造业的影响【摘要】自 1978 年开始，政府宏观政策开放中国制药业市场吸收外商资金，2001 年 12 月 11 日中国正式成为世贸组织成员以后，许多跨国医药企业通过合作或者收购兼并等方式进军中国医药领域。基于上述背景对外商资金直接投入中国医药制造业的研究，不仅能够帮助我们完备相关行业政策的制定，还利于我们对中国制药业市场架构的梳理。基于以上分析，本文将以我国医药制造业为研究对象，搜集整理了国内外外商直接投资理论的研究成果和进展，分析了中国医药制造业利用外商直接投资现状，指出了外商直接投资对中国医药制造业的积极影响与消极影响，并提出了注重发挥外资优惠政策导向作用，积极促成国内企业规模化；在企业自身层面，应当合理利用外资资源，增强企业竞争实力，争取优势股权分配方式及合作模式等措施。【关键词】外商直接投资；中国医药制造业；影响The impact of foreign direct investment on China's pharmaceutical manufacturing industry[Abstract] Since 1978, the government's macro policy has opened up the Chinese pharmaceutical industry market to absorb foreign funds. After China officially became a WTO member on December 11, 2001, many multinational pharmaceutical companies have entered the Chinese pharmaceutical industry through cooperation or mergers and acquisitions. Based on the above background, the direct investment of foreign funds into the Chinese pharmaceutical manufacturing industry can not only help us complete the formulation of relevant industry policies, but also help us sort out the market structure of the Chinese pharmaceutical industry.Based on the above analysis, this article will take China's pharmaceutical manufacturing industry as the research object, collect and organize the research results and progress of foreign direct investment theory at home and abroad, analyze the current situation of China's pharmaceutical manufacturing industry using foreign direct investment, and point out that foreign direct inves...
